These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 31349905)

  • 1. Clinical and translational advances in esophageal squamous cell carcinoma.
    Reichenbach ZW; Murray MG; Saxena R; Farkas D; Karassik EG; Klochkova A; Patel K; Tice C; Hall TM; Gang J; Parkman HP; Ward SJ; Tétreault MP; Whelan KA
    Adv Cancer Res; 2019; 144():95-135. PubMed ID: 31349905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sparse Representation-Based Patient-Specific Diagnosis and Treatment for Esophageal Squamous Cell Carcinoma.
    Huang B; Zhong N; Xia L; Yu G; Cao H
    Bull Math Biol; 2018 Aug; 80(8):2124-2136. PubMed ID: 29869044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated analysis highlights multiple long non‑coding RNAs and their potential roles in the progression of human esophageal squamous cell carcinoma.
    Li CY; Zhang WW; Xiang JL; Wang XH; Wang JL; Li J
    Oncol Rep; 2019 Dec; 42(6):2583-2599. PubMed ID: 31638253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue protein biomarker candidates to predict progression of esophageal squamous cell carcinoma and precancerous lesions.
    Wang M; Smith JS; Wei WQ
    Ann N Y Acad Sci; 2018 Dec; 1434(1):59-69. PubMed ID: 29882970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics identification of lncRNA biomarkers associated with the progression of esophageal squamous cell carcinoma.
    Yu J; Wu X; Huang K; Zhu M; Zhang X; Zhang Y; Chen S; Xu X; Zhang Q
    Mol Med Rep; 2019 Jun; 19(6):5309-5320. PubMed ID: 31059058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular landscape of esophageal cancer: implications for early detection and personalized therapy.
    Talukdar FR; di Pietro M; Secrier M; Moehler M; Goepfert K; Lima SSC; Pinto LFR; Hendricks D; Parker MI; Herceg Z
    Ann N Y Acad Sci; 2018 Dec; 1434(1):342-359. PubMed ID: 29917250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy as a cytoprotective mechanism in esophageal squamous cell carcinoma.
    Hall TM; Tétreault MP; Hamilton KE; Whelan KA
    Curr Opin Pharmacol; 2018 Aug; 41():12-19. PubMed ID: 29677645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer stem cells in esophageal cancer and response to therapy.
    Harada K; Pool Pizzi M; Baba H; Shanbhag ND; Song S; Ajani JA
    Cancer; 2018 Oct; 124(20):3962-3964. PubMed ID: 30368777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verrucous esophageal carcinoma is a unique indolent subtype of squamous cell carcinoma: a systematic review and individual patient regression analysis.
    Li DK; Haffar S; Horibe M; Homsi HA; Zukerberg L; Murad MH; Visrodia KH; Gala M; Katzka DA; Bazerbachi F
    J Gastroenterol; 2021 Jan; 56(1):12-24. PubMed ID: 33079233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized and targeted therapy of esophageal squamous cell carcinoma: an update.
    Liu Y; Xiong Z; Beasley A; D'Amico T; Chen XL
    Ann N Y Acad Sci; 2016 Oct; 1381(1):66-73. PubMed ID: 27399176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
    Wang WT; Guo CQ; Cui GH; Zhao S
    World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target.
    Ma S; Paiboonrungruan C; Yan T; Williams KP; Major MB; Chen XL
    Ann N Y Acad Sci; 2018 Dec; 1434(1):164-172. PubMed ID: 29752726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etiology, cancer stem cells and potential diagnostic biomarkers for esophageal cancer.
    Liu K; Zhao T; Wang J; Chen Y; Zhang R; Lan X; Que J
    Cancer Lett; 2019 Aug; 458():21-28. PubMed ID: 31125642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of chemotherapeutics for unresectable advanced esophageal cancer.
    Imazeki H; Kato K
    Expert Rev Anticancer Ther; 2020 Dec; 20(12):1083-1092. PubMed ID: 32820965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in treating oesophageal cancer.
    Harada K; Rogers JE; Iwatsuki M; Yamashita K; Baba H; Ajani JA
    F1000Res; 2020; 9():. PubMed ID: 33042518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squamous Cell Carcinoma of the Esophagus.
    Codipilly DC; Wang KK
    Gastroenterol Clin North Am; 2022 Sep; 51(3):457-484. PubMed ID: 36153105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma.
    Ohashi S; Miyamoto S; Kikuchi O; Goto T; Amanuma Y; Muto M
    Gastroenterology; 2015 Dec; 149(7):1700-15. PubMed ID: 26376349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approach to Localized Squamous Cell Cancer of the Esophagus.
    Weidenbaum C; Gibson MK
    Curr Treat Options Oncol; 2022 Oct; 23(10):1370-1387. PubMed ID: 36042147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma.
    Qi B; Lu JG; Yao WJ; Chang TM; Qin XG; Ji YH; Wang TY; Liu SG; Li HC; Liu YZ; Zhao BS
    World J Gastroenterol; 2015 Jun; 21(22):6884-91. PubMed ID: 26078564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latest insights into the global epidemiological features, screening, early diagnosis and prognosis prediction of esophageal squamous cell carcinoma.
    Zhao YX; Zhao HP; Zhao MY; Yu Y; Qi X; Wang JH; Lv J
    World J Gastroenterol; 2024 May; 30(20):2638-2656. PubMed ID: 38855150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.